-
1مورد إلكتروني
مصطلحات الفهرس: letter, lung edema, malignant hypertension/dt [Drug Therapy], middle aged, multiple sclerosis/dt [Drug Therapy], priority journal, hemolysis, human tissue, kidney biopsy, acute kidney failure, adult, case report, clinical article, creatinine blood level, drug withdrawal, dyspnea, female, human, proteinuria, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/si [Side Effect], antihypertensive agent/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], beta1a interferon/dt [Drug Therapy], beta1a interferon/sc [Subcutaneous Drug Administration], creatinine/ec [Endogenous Compound], teriflunomide/dt [Drug Therapy], Letter
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36225Test
Internal Medicine Journal
Click here for full text options
LibKey Link -
2مورد إلكتروني
مصطلحات الفهرس: letter, lung edema, malignant hypertension/dt [Drug Therapy], middle aged, multiple sclerosis/dt [Drug Therapy], priority journal, hemolysis, human tissue, kidney biopsy, acute kidney failure, adult, case report, clinical article, creatinine blood level, drug withdrawal, dyspnea, female, human, proteinuria, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/si [Side Effect], antihypertensive agent/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], beta1a interferon/dt [Drug Therapy], beta1a interferon/sc [Subcutaneous Drug Administration], creatinine/ec [Endogenous Compound], teriflunomide/dt [Drug Therapy], Letter
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36225Test
Internal Medicine Journal
LibKey Link -
3مورد إلكتروني
مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link -
4مورد إلكتروني
مصطلحات الفهرس: hemolytic uremic syndrome/th [Therapy], hemolytic uremic syndrome/dt [Drug Therapy], human, kidney biopsy, lethargy/co [Complication], maintenance therapy, male, malignant hypertension/co [Complication], malignant hypertension/dt [Drug Therapy], nausea/co [Complication], nonhuman, Norovirus, plasmapheresis, relapse, review, seizure/co [Complication], thrombocyte count, thrombocytopenia/di [Diagnosis], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/th [Therapy], treatment duration, urea blood level, vomiting, complement factor H/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], haptoglobin/ec [Endogenous Compound], hemoglobin/ec [Endogenous Compound], labetalol/dt [Drug Therapy], lactate dehydrogenase/ec [Endogenous Compound], lercanidipine/dt [Drug Therapy], ramipril/dt [Drug Therapy], von Willebrand factor cleaving proteinase/ec [Endogenous Compound], complement factor H gene, fecal shiga toxin test, helmet cell, acute kidney failure/di [Diagnosis], adult, case report, cells, diarrhea, erythrocyte, erythrocyte disorder, family history, feces analysis, gene mutation, genetic screening, headache/co [Complication], hematuria/di [Diagnosis], hemodialysis, hemolysis, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39530Test
Nephrology
Click here for full text options
LibKey Link -
5مورد إلكتروني
مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link -
6مورد إلكتروني
مصطلحات الفهرس: hemolytic uremic syndrome/th [Therapy], hemolytic uremic syndrome/dt [Drug Therapy], human, kidney biopsy, lethargy/co [Complication], maintenance therapy, male, malignant hypertension/co [Complication], malignant hypertension/dt [Drug Therapy], nausea/co [Complication], nonhuman, Norovirus, plasmapheresis, relapse, review, seizure/co [Complication], thrombocyte count, thrombocytopenia/di [Diagnosis], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/th [Therapy], treatment duration, urea blood level, vomiting, complement factor H/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], haptoglobin/ec [Endogenous Compound], hemoglobin/ec [Endogenous Compound], labetalol/dt [Drug Therapy], lactate dehydrogenase/ec [Endogenous Compound], lercanidipine/dt [Drug Therapy], ramipril/dt [Drug Therapy], von Willebrand factor cleaving proteinase/ec [Endogenous Compound], complement factor H gene, fecal shiga toxin test, helmet cell, acute kidney failure/di [Diagnosis], adult, case report, cells, diarrhea, erythrocyte, erythrocyte disorder, family history, feces analysis, gene mutation, genetic screening, headache/co [Complication], hematuria/di [Diagnosis], hemodialysis, hemolysis, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39530Test
Nephrology
Click here for full text options
LibKey Link -
7مورد إلكتروني
مصطلحات الفهرس: thrombotic thrombocytopenic purpura/ep [Epidemiology], thrombotic thrombocytopenic purpura/th [Therapy], treatment duration, corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], von Willebrand factor cleaving proteinase/ec [Endogenous Compound], medical history, adult, allergic reaction/co [Complication], article, Australia, Australian, disease association, disease registry, female, human, immunosuppressive treatment, laboratory diagnosis, major clinical study, male, patient information, plasma transfusion, plasmapheresis, practice guideline, priority journal, thrombocyte transfusion, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39661Test
Internal Medicine Journal
LibKey Link -
8مورد إلكتروني
مصطلحات الفهرس: clinical feature, drug efficacy, epileptic state/co [Complication], epileptic state/dt [Drug Therapy], female, human, hypertension, male, plasmapheresis, refractory thrombocytopenia/dt [Drug Therapy], refractory thrombocytopenia/th [Therapy], single drug dose, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], treatment outcome, anticonvulsive agent/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], priority journal, adult, article, case report, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31857Test
Click here for full text options
LibKey Link -
9مورد إلكتروني
مصطلحات الفهرس: clinical feature, drug efficacy, epileptic state/co [Complication], epileptic state/dt [Drug Therapy], female, human, hypertension, male, plasmapheresis, refractory thrombocytopenia/dt [Drug Therapy], refractory thrombocytopenia/th [Therapy], single drug dose, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], treatment outcome, anticonvulsive agent/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], priority journal, adult, article, case report, Article